Up-regulation of fibronectin and tissue transglutaminase promotes cell invasion involving increased association with integrin and MMP expression in A431 cells

Anticancer Research

Volumn 30, Issue 10, 2010, Pages 4177-4186

  Chen, Shih Hsun ^a   Lin, Chun Yu ^a   Lee, Lung Ta ^b   Chang, Geen Dong ^a   Lee, Ping Ping ^c   Hung, Chin Chun ^c   Kao, Wen Te ^c   Tsai, Pei Hsun ^a   Schally, Andrew V ^d   Hwang, Jiuan Jiuan ^e   Lee, Ming Ting ^a,c  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b CHING KUO INSTITUTE OF MANAGEMENT AND HEALTH   (Taiwan)

^c INSTITUTE OF BIOLOGICAL CHEMISTRY   (Taiwan)

^d Veterans Affairs Healthcare System   (United States)

^e NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

A431 cell; Fibronectin; MMP 9; TG2

Indexed keywords

BETA1 INTEGRIN; BETA3 INTEGRIN; FIBRONECTIN; GELATINASE A; GELATINASE B; INTEGRIN; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY; SMALL INTERFERING RNA; STROMELYSIN;

ARTICLE; CANCER INVASION; CELL ADHESION; CELL INVASION; CELL LINE; CELL MIGRATION; CELL STRAIN A 431; CONTROLLED STUDY; ENZYME RELEASE; IN VITRO STUDY; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; UPREGULATION;

ANTIGENS, CD29; CELL LINE, TUMOR; FIBRONECTINS; GENE KNOCKDOWN TECHNIQUES; HUMANS; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; RNA, SMALL INTERFERING; TRANSGLUTAMINASES; UP-REGULATION;

EID: 78650255565     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Stemlicht MD and Werb Z: How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 17: 463-516, 2001. (Pubitemid 33096184)
2. Collier IE, Wilhelm SM, Eisen AZ, Marmer BL, Grant GA, Seltzer JL, Kronberger A, He CS, Bauer EA and Goldberg GI: H-ras oncogene-transformed human bronchial epithelial cells. (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen, J Biol Chem 263: 6579-6587, 1988.
3. Clark EA, Golub TR, Lander ES and Hynes RO: Genomic analysis of metastasis reveals an essential role for RhoC. Nature 406: 532-535, 2000.
4. Wyckoff JB, Segall JE and Condeelis JS: The collection of the motile population of cells from a living tumor. Cancer Res 60: 5401-5404, 2000.
5. Okoh V, Young GD, Winokur TS and Garver RI Jr: A novel assay for the quantification of invasion from raft cultures of lung carcinomas. Clin Exp Metastasis 21: 1-6, 2004. (Pubitemid 38365651)
6. Saiki I, Fujii H, Yoneda J, Abe F, Nakajima M, Tsuruo T and Azuma I: Role of aminopeptidase N (CD13) in tumor-cell invasion and extracellular matrix degradation. Int J Cancer 54: 137-143, 1993. (Pubitemid 23137011)
7. Kao WT, Lin CY, Lee LT, Lee PP, Hung CC, Lin YS, Chen SH, Ke FC, Hwang JJ, Lee MT: Investigation of MMP-2 and -9 in a highly invasive A431 tumor cell sub-line selected from a Boyden chamber assay. Anticancer Res 28: 2109-2120, 2008.
8. Akiyama SK, Olden K and Yamada KM: Fibronectin and integrins in invasion and metastasis. Cancer Metastasis Rev 14: 173-189, 1995.
9. Shibata K, Kikkawa F, Nawa A, Suganuma N and Hamaguchi M: Fibronectin secretion from human peritoneal tissue induces Mr 92,000 type IV collagenase expression and invasion in ovarian cancer cell lines. Cancer Res 57: 5416-5420, 1997. (Pubitemid 27516383)
10. Werb Z, Tremble PM, Behrendtsen O, Crowley E and Damsky CH: Signal transduction through the fibronectin receptor induces collagenase and stromelysin gene expression. J Cell Biol 109: 877-889, 1989. (Pubitemid 19197045)
11. Akimov SS, Krylov D, Fleischman LF and Belkin AM: Tissue transglutaminase is an integrin-binding adhesion co-receptor for fibronectin. J Cell Biol 148: 825-838, 2000.
12. Folk JE and Finlayson JS: The epsilon-(gamma-glutamyl)lysine crosslink and the catalytic role of transglutaminases. Adv Protein Chem 31: 1-133, 1977.
13. Nakaoka H, Perez DM, Baek KJ, Das T, Husain A, Misono K, Im MJ and Graham RM: Gh: a GTP-binding protein with transglutaminase activity and receptor signaling function. Science 264: 1593-1596, 1994.
14. Iismaa SE, Wu MJ, Nanda N, Church WB and GrahamRM: GTP binding and signaling by Gh/transglutaminase II involves distinct residues in a unique GTP-binding pocket. J Biol Chem 275: 18259-18265, 2000. (Pubitemid 30414778)
15. Martinez J, Chalupowicz DG, Roush RK, Sheth and Barsigian C: Transglutaminase-mediated processing of fibronectin by endothelial cell monolayers. Biochemistry 33: 2538-2545, 1994. (Pubitemid 24099661)
16. Turner PM and Lorand L: Complexation of fibronectin with tissue transglutaminase. Biochemistry 28: 628-635, 1989.
17. Gaudry CA, Verderio E, Aeschlimann D, Cox A, Smith C and Griffin M: Cell surface localization of tissue transglutaminase is dependent on a fibronectin-binding site in its N-terminal beta-sandwich domain. J Biol Chem 274: 30707-30714, 1999. (Pubitemid 129576814)
18. Radek JT, Jeong JM, Murthy SN, Ingham KC and Lorand L: Affinity of human erythrocyte transglutaminase for a 42-kDa gelatin-binding fragment of human plasma fibronectin. Proc Natl Acad Sci 90: 3152-3156, 1993.
19. Akimov SS, and Belkin AM: Cell surface tissue transglutaminase is involved in adhesion and migration of monocytic cells on fibronectin. Blood 98: 1567-1576, 2001.
20. Balklava Z, Verderio E, Collighan R, Gross S, Adams J and Griffin M: Analysis of tissue transglutaminase function in the migration of Swiss 3T3 fibroblasts: the active-state conformation of the enzyme does not affect cell motility but is important for its secretion. J Biol Chem 277: 16567-16575, 2002. (Pubitemid 34967673)
21. Jones RA, Nicholas B, Mian S, Davies PJ and Griffin M: Reduced expression of tissue transglutaminase in a human endothelial cell line leads to changes in cell spreading, cell adhesion and reduced polymerisation of fibronectin. J Cell Sci 110: 2461-2472, 1997. (Pubitemid 127699160)
22. Stephens P, Grenard P, Aeschlimann P, Langley M, Blain E, Errington R, Kipling Thomas D and Aeschlimann D: Crosslinking and G-protein functions of transglutaminase 2 contribute differentially to fibroblast wound healing responses. J Cell Sci 117: 3389-3403, 2004.
23. van Groningen JJ, Klink SL, Bloemers HP and Swart GW: Expression of tissue-type transglutaminase correlates positively with metastatic properties of human melanoma cell lines. Int J Cancer 60: 383-387, 1995.
24. Jiang D, Ying W, Lu Y, Wan J, Zhai Y, Liu W, Zhu Y, Qiu Z, Qian X and He F: Identification of metastasis-associated proteins by proteomic analysis and functional exploration of interleukin-18 in metastasis. Proteomics 3: 724-737, 2003.
25. Mehta K, Fok J, Miller FR, Koul D and Sahin: Prognostic significance of tissue transglutaminase in drug-resistant and metastatic breast cancer. Clin Cancer Res 10: 8068-8076, 2004. (Pubitemid 39587548)
26. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal Biochem 72: 248-254, 1976.
27. Albini A, Iwamoto Y, Kleinman HK, Martin GR, Aaronson SA, Kozlowski JM and McEwan RN: A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 47: 3239-3245, 1987. (Pubitemid 17082655)
28. Heussen C and Dowdle BB: Electrophoretic analysis of plasminogen activators in Polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal Biochem 102: 196-202, 1980.
29. He C: Molecular mechanism of transcriptional activation of human gelatinase B by proximal promoter. Cancer Lett 106: 185-191, 1996.
30. Kornberg L, Earp HS, Parsons JT, Schaller M and Juliano RL: Cell adhesion or integrin clustering increases phosphorylation of a focal adhesion-associated tyrosine kinase. J Biol Chem 267: 23439-23442, 1992.
31. Chen Q, Kinch MS, Lin TH, Burridge K and Juliano RL: Integrin-mediated cell adhesion activates mitogen-activated protein kinases, J Biol Chem 269: 26602-26605, 1994.
32. Chandrasekar B, Mummidi S, Mahimainathan L, Patel DN, Bailey SR, Imam SZ, Greene WC and Valante AJ: Interleukin-18-induced human coronary artery smooth muscle cell migration is dependent on NF-kappa B- and AP-1-mediated matrix metalloproteinase-9 expression, and is inhibited by atorvastatin. J Biol Chem 281: 15099-15109, 2006.
33. Johnson TS, Knight CR, el-Alaoui S, Mian S, Rees RC, Gentile V, Davies PJ and Griffin M: Transfection of tissue transglutaminase into a highly malignant hamster fibrosarcoma leads to a reduced incidence of primary tumour growth. Oncogene 9: 2935-2942, 1994.
34. Haroon ZA, Lai TS, Hettasch JM, Lindberg RA, Dewhirst MW and Greenberg CS: Tissue transglutaminase is expressed as a host response to tumor invasion and inhibits tumor growth. Lab Invest 79: 1679-1686, 1999.
35. Janiak A, Zemskov EA and Belkin AM: Cell surface transglutaminase promotes RhoA activation via integrin clustering and suppression of the Src-p190RhoGAP signaling pathway. Mol Biol Cell 17: 1606-1619, 2006.
36. Mangala LS, Fok JY, Zorrilla-Calancha IR, Verma A and Mehta K: Tissue transglutaminase expression promotes cell attachment, invasion and survival in breast cancer cells. Oncogene 26: 2549-2570, 2007.
37. Herman JF, Mangala LS and Mehta K: Implications of increased tissue transglutaminase (TG2) expression in drug-resistant breast cancer (MCF-7) cells. Oncogene 25: 3049-3058, 2006.
38. Hanada M, Tanaka K, Matsumoto Y, Nakatani F, Sakimura R, Matsunobu T, Li X, Okada T, Nakamura T, Takasaki M and Iwamoto Y: Focal adhesion kinase is activated in invading fibrosarcoma cells and regulates metastasis. Clin Exp Metastasis 22: 485-494, 2005.
39. Hsia DA, Mitra SK, Hauck CR, Streblow DN, Nelson JA, Ilic D, Huang S, Li E, Nemerow GR, Leng J, Spencer KS, Cheresh DA and Schlaepfer DD: Differential regulation of cell motility and invasion by FAK. J Cell Biol 160: 753-767, 2003.
40. Kang SK, Lee JY, Chung TW and Kim CH: Overexpression of transglutaminase 2 accelerates the erythroid differentiation of human chronic myelogenous leukemia K562 cell line through PI3K/Akt signaling pathway. FEBS Lett 577: 361-366, 2004.
41. Westermarck J and Kahari VM: Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J 13: 781-792, 1999.
42. Mann AP, Verma A, Sethi G, Manavathi B, Wang H, Fok JY, Kunnumakkara AB, Kumar R, Aggarwal BB and Mehta K: Overexpression of tissue transglutaminase leads to constitutive activation of nuclear factor-{kappa}B in cancer cells: delineation of a novel pathway. Cancer Res 66: 8788-8795, 2006.